In conclusion, NLRC5 promotes the malignant biological behaviors of NSCLC cells by activating the PI3K/AKT signaling pathway via regulating CEACAM1 expression under normoxia and hypoxia. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.